NCT01053494
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
Clinical trial condition
Lymphoma, Extranodal NK-T-Cell
Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.
157 public trials
17 recruiting studies
Lymphoma, Extranodal NK-T-Cell trial results
NCT01129193
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +118 more
- Locations
-
- The Ohio State University James Cancer Hospital Columbus, Ohio, United States
Completed
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT00963274
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +23 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
- University of North Carolina Chapel Hill, North Carolina, United States
- Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee, United States
Completed
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
NCT00569309
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +27 more
- Locations
-
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT00445952
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
- Locations
-
- Institut Jules Bordet Brussels, Belgium
- CHU de Grenoble - Hopital de la Tronche Grenoble, France
- German Hodgkin's Lymphoma Study Group Cologne, Germany
- Ospedale San Martino Genoa, Italy
Completed
Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma
NCT02825147
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Shanghai Ruijin Hospital Shanghai, China
NCT01254578
- Conditions
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma
NCT02276248
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, Beijing Municipality, China
NCT00448357
- Conditions
- Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT00072514
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States